Factors affecting morbidity, mortality, and survival in patients undergoing ivor lewis esophagogastrectomy

Annals of Surgery

Volumn 231, Issue 5, 2000, Pages 635-643

  Karl, Richard C ^a   Schreiber, Robert ^a   Boulware, David ^b   Baker, Scott ^a   Coppola, Domenico ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; DEATH; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SAFETY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0034095478     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200005000-00003     Document Type: Article

References (38)

1. Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957; 41:881-894.
2. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989; 64:526-530.
3. Ellis FH, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved stage criteria. J Thorac Cardiovasc Surg 1997; 113: 836-846.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-1289.
5. Devesa S, Blot W, Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83:2049-2053.
6. Siewert JR, Stein HJ, Sendler A, Fink U. Surgical resection for cancer of the cardia. Semin Surg Oncol 1999; 17:125-131.
7. Pommier RF, Vetto JT, Ferris BL, et al. Relationships between operative approaches and outcomes in esophageal cancer. Am J Surg 1998; 175:422-425.
8. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999; 230:392-403.
9. Lewis I. The surgical treatment of carcinoma of the esophagus, with special reference to a new operation for growths of the middle third. Br J Surg 1946; 34:18-31.
10. Gluch L, Smith RC, Bambach CP, Brown AR. Comparison of outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg 1999; 23:271-276.
11. Bossett JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337:161-167.
12. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467.
13. Barash P, Cullen B, Stoelting R. Clinical Anesthesia. 2nd ed. Philadelphia: JB Lippincott; 1992:560.
14. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott; 1992:75-79.
15. Owen JW, Balfe DM, Koehler RE, et al. Radiologic evaluation of complications after esophagogastrectomy. AJR 1983; 140:1163-1169.
16. Anbari MM, Levine MS, Cohen RB, et al. Delayed leaks and fistulas after esophagogastrectomy: radiologic evaluation. AJR 1993; 160: 1217-1220.
17. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951; 38:141-149.
18. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34:187-220.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
20. Lozac'h P, Topart P, Perramant M. Ivor Lewis procedure for epidermoid carcinoma of the esophagus. A series of 264 patients. Semin Surg Oncol 1997; 13:238-244.
21. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983; 85:59-71.
22. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Systemic lymph node dissection for esophageal cancer: effective or not? Dis Esoph 1994; 7:2-13.
23. National Center for Health Statistics. Health, United States, 1996-97 and Injury Chartbook. Hyattsville, MD: Public Health Service; 1997 DHHS Pub. No. (PHS) 97-1232.
24. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. JAMA 1994; 272:205-211.
25. Kabat GC, Ng SKC, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 1993; 4:123-132.
26. Brown LM, Silverman DT, Pottern LM, et al. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994; 5:333-340.
27. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89:1277-1284.
28. Quintiliani L, Buzzonetti A, DiGirolamo M, et al. Effects of blood transfusion on the immune responsiveness and survival of cancer patients: a prospective study. Transfusion 1991; 31:713-718.
29. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998; 41:451-459.
30. Heiss MM, Allgayer H, Gruetzner KU, et al. Prognostic influence of blood transfusion on minimal residual disease in resection gastric cancer patients. Anticancer Res 1997; 17:2657-2661.
31. Molland G, Dent OF, Chapuis PH, et al. Transfusion does not influence patient survival after resection of colorectal cancer. Aust NZ J Surg 1995; 65:592-595.
32. Donohue JH, Williams S, Cha S, et al. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group Study. J Clin Oncol 1995; 13:1671-1678.
33. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994; 167:256-260.
34. Craig SR, Adam DJ, Yap PL, et al. Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg 1998; 66:356-361.
35. Tachikawa D, Inada S, Kotoh T, et al. An evaluation of malignancy and prognostic factors based on mode of lymph node metastasis in esophageal carcinoma. Surg Today 1999; 29:1131-1135.
36. Sugimachi K, Matsuura H, Kai H, et al. Prognostic factors of esophageal carcinoma: univariate and multivariate analyses. J Surg Oncol 1986; 31:108-112.
37. Roth JA, Putnam JB. Surgery for cancer of the esophagus. Sem Oncol 1994; 21:453-461.
38. Watson A. Operable esophageal cancer: current results from the West. World J Surg 1994; 18:361-366.